In 2006 Adam Stone joined Perceptive. Prior to Perceptive he was a senior analyst at Ursus Capital. During his five years there Adam focused on biotech and specialty pharmaceuticals. Adam graduated, with honors, from Princeton University with a B.A. in molecular biology.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Prometheus Biosciences | Board of Directors | Nov 9, 2020 | — | Detail |
Prometheus Biosciences | Board Member | Nov 1, 2020 | — | Detail |
Xontogeny | Board of directors | — | — | Detail |